Japanese stocks are a two-way bet
If a global recovery takes hold, Japan’s export-orientated businesses will enjoy a surge. But if growth stays weak, its corporate cash mountain will serve as a good bulwark.

Japan has dodged the worst of the pandemic, but its economy has not been so lucky. Despite its relatively elderly population, death rates from Covid-19 have been among the lowest in major countries. Yet the world’s third-largest economy still entered a recession in the first quarter.
More bad data is on the way; economists predict a 20% annualised slump in GDP for the second quarter, which coincided with a national state of emergency.
The economy has been gradually reopening since the end of May, with finance minister Taro Aso declaring that activity “seems to have hit bottom”. The benchmark Topix stock index is down 6% so far this year, but has rallied 28% since a mid-March low.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Lavish stimulus
Japanese policymakers have responded to the downturn with aggressive stimulus measures. The central bank, long a monetary innovator, has pledged to buy a maximum of ¥12trn (£88bn) in stock exchange traded funds (ETFs) this year. Previous purchases mean that the Bank of Japan already owns roughly 8% of the country’s entire equity market, says Scott Longley for etfstream.com. The bank has also pledged to take its stock of corporate debt up to ¥20trn (£150bn). Politicians are also testing “the limits” of fiscal stimulus, says The Economist. Tokyo has pledged $2.2trn in support, including loan guarantees – equivalent to 40% of the country’s entire GDP.
Japan’s government debt is already the world’s highest at 240% of GDP and is heading higher still. The wall of budgetary “red ink this year tests the limits of comprehension”. Yet with the central bank backstopping government bond prices, markets have simply “yawned in response”.
Overshadowed by the surge on Wall Street, Japanese shares have been quietly outperforming European and emerging markets this year, says Mike Bird in The Wall Street Journal.
On a forward price/earnings ratio of 15.7, stock valuations remain reasonable. Japanese companies look like a two-way bet. If a global recovery takes hold then Japan’s export-orientated electronics and communications businesses will enjoy a surge. But if growth stays weak then the mammoth ¥280trn (£2trn) corporate cash mountain is a mighty bulwark.
Those cash reserves underpin the country’s attractions as a dividend destination, says Moxy Ying on Bloomberg. Japanese stocks currently yield an average 2.5%, similar to major continental bourses and much better than the S&P 500. Robust balance sheets, dividends and “political stability” are the key attractions, says Societe Generale. The bank thinks that the Land of the Rising Sun looks like the “perfect place to be”.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Company directors face new ID checks – how to avoid paying hundreds on verification
Company directors could end up paying hundreds of pounds to comply with new identity checks but it is possible to comply without paying a penny
-
Will petrol prices rise this year?
Petrol has been relatively cheap in the UK so far in 2025, hitting a four-year low in May. But with conflict in the Middle East making the price of oil more volatile, will petrol become more expensive?
-
The British railway industry is in rude health – here's why investors should jump aboard
The railway industry has bounced back from the devastating impact of the pandemic and is entering a new phase of development – and profitability
-
Infrastructure investing: a haven of stable growth amid market turmoil
From booming construction in emerging markets to digital and green transitions, the infrastructure sector offers security, returns and long-term opportunities
-
The costly myth of “sell in May”
Opinion May 2025's strong returns for US stocks have once again shown that putting too much weight on seasonal patterns will only make investors poorer, says Max King
-
Who’s driving Tesla?
As Elon Musk steps back from government with his eyes on the stars, investors ask if he’s still behind the wheel at his electric-car maker.
-
Investment opportunities in the world of Coca-Cola
There is far more to Coca-Cola than just one giant firm. The companies that bottle and distribute the ubiquitous soft drink are promising investments in their own right.
-
Streaming services are the new magic money tree for investors – but for how long?
Opinion Streaming services are in full bloom and laden with profits, but beware – winter is coming, warns Matthew Lynn
-
'Pension funds shouldn't be pushed into private equity sector'
Opinion The private-equity party is over, so don't push pension funds into the sector, says Merryn Somerset Webb.
-
Greg Abel: Warren Buffett’s heir takes the throne
Greg Abel is considered a safe pair of hands as he takes centre stage at Berkshire Hathaway. But he arrives after one of the hardest acts to follow in investment history, Warren Buffett. Can he thrive?